Results 271 to 280 of about 1,015,585 (380)
Accessible communication tools for surgical site infection monitoring and prevention in joint reconstruction: Feasibility study [PDF]
Aladegbami, Bola+10 more
core +1 more source
We performed a survey on lifestyle habits aimed at reducing the risks associated with immunosuppression in kidney transplant recipients. We found gaps in dental hygiene, sunscreen use, vaccination, and consumption of high‐risk foods. Cultural and economic factors influenced adherence.
Tamara Ruiz‐Merlo+11 more
wiley +1 more source
Transition support arrangements to support new graduate & novice nurses entry into perioperative nursing: A scoping review. [PDF]
Nijkamp N, Calleja P, Sahay A.
europepmc +1 more source
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki+6 more
wiley +1 more source
Comprehensive management of vulvovaginal cancers
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues+5 more
wiley +1 more source
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris+12 more
wiley +1 more source
Urothelial carcinoma: Perioperative considerations from top to bottom
Abstract Urothelial carcinoma is an aggressive entity that is associated with significant morbidity, but there have been major advances in both our understanding of and treatment options for patients with this disease. In this review, the authors focus on novel therapeutic and diagnostic approaches in the perioperative setting, with an emphasis on ...
Wesley Yip+8 more
wiley +1 more source
Abstract The discovery of activating mutations in the epidermal growth factor receptor (EGFR) gene has revolutionized the management of lung cancer, enabling the development of targeted tyrosine kinase inhibitors (TKIs). These therapies offer improved survival and reduced side effects compared with conventional treatments.
Maxime Borgeaud+9 more
wiley +1 more source